Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
From outside firms

Analysis and Perspectives

Commentary and analysis from outside consulting and policy firms. Not part of Medicaid Monitor's independently scored news coverage. Each piece links back to the firm's original publication.

Milliman · Aug 22

Life Sciences Firms Urged to Court ACOs as Value-Based Care Expands Across Medicaid, Medicare

Milliman argues life sciences companies should build strategies for engaging accountable care organizations (ACOs) given the growing share of Medicaid, Medicare, and commercial lives in value-based care arrangements, including a rising share of downside-risk contracts. While Medicaid VBC penetration (29.1% of lives, 21.1% in two-sided risk) is cited as supporting data, the piece's core audience and recommendations target pharma/life sciences strategy rather than Medicaid managed care operations directly.

Read at milliman.com →
Milliman · Aug 12

Milliman Analysis Forecasts Major Medicaid and Marketplace Enrollment Shifts Following End of Enhanced ACA Subsidies and New Federal Policy Changes

This benchmarking report examines enrollment dynamics in Medicaid and individual marketplace insurance since 2020, finding that subsidized marketplace growth was concentrated among near-poverty populations while Medicaid changes varied significantly by state. With enhanced premium subsidies set to expire and new federal rules on income verification, premium subsidy repayment, and potential Medicaid work requirements taking effect, the analysis projects substantial enrollment volatility in 2026—including an estimated 3.5 million losing individual market coverage. For Medicaid MCOs and state programs, this signals potential membership shifts, redeterminations challenges, and the need to prepare operational systems for new eligibility verification and work requirement administration.

milliman.com →
Milliman · Aug 4

How Providers Should Audit Value-Based Care Payment Reconciliations

This Milliman white paper outlines how provider organizations should approach reconciliation and auditing of value-based care contracts, emphasizing the need to validate payer calculations on attribution, risk adjustment, and shared savings before accepting final settlements. While not Medicaid-specific, the guidance is relevant to providers and plans operating value-based arrangements within Medicaid managed care, where similar reconciliation disputes and claims-lag issues commonly arise.

milliman.com →
Milliman · Jul 10

Medicare Advantage LTC Benefits Fall Short of Comprehensive Coverage, Leaving Gaps Medicaid Must Fill

Milliman analyzes the limitations of long-term care supplemental benefits now permitted in Medicare Advantage plans since 2019, finding they cover only a fraction of typical LTC costs that run $70,000-$130,000 annually. The piece examines what MA plans can offer for home health, adult day care, and caregiver support versus the comprehensive custodial care needs of aging beneficiaries. This matters for Medicaid managed care because when MA benefits are exhausted, beneficiaries often spend down to Medicaid eligibility, shifting LTC costs to state programs and dual-eligible plans.

milliman.com →
Milliman · Jun 30

Milliman Releases 2024 Financial Benchmark Data for Medicaid MCOs

Milliman's annual benchmarking report analyzes key financial performance metrics for Medicaid managed care organizations using standardized NAIC reporting data from 2024. The report provides comparative financial benchmarks that MCO finance teams, state Medicaid agencies, and consultants use to assess plan performance, evaluate rate adequacy, and identify industry trends. This type of standardized financial analysis is a core reference tool for compliance officers reviewing financial solvency and state officials conducting rate-setting and contract oversight.

milliman.com →
Milliman · Jun 15

Adding Social Determinants to Medicaid Risk Adjustment Reduces Payment Volatility, Especially for Low-Morbidity Populations

Milliman research finds that incorporating social determinants of health into Medicaid managed care risk adjustment models produces modestly better payment accuracy and reduces financial volatility for MCOs and ACOs. The improvement is most pronounced for beneficiaries with lower medical complexity but higher social risk, where morbidity-only models systematically underpay plans—suggesting SDOH factors help correct revenue distortions when members face barriers to care that suppress diagnosis coding. The findings offer technical guidance for state Medicaid agencies considering updates to capitation rate-setting methodologies.

milliman.com →
Milliman · Jun 11

Gene Therapy Access Gaps for Sickle Cell Disease Carry Big Medicaid Implications

Milliman examines barriers limiting patient access to new sickle cell disease (SCD) cell and gene therapies, including treatment center geography, hospital capacity, long lead times, and ancillary services like fertility preservation. Because SCD disproportionately affects Medicaid beneficiaries, the paper's recommendations on improving insurance coverage design are relevant for Medicaid managed care plans grappling with high-cost specialty drug coverage and network adequacy for rare disease treatment.

milliman.com →
Milliman · Jun 4

Rethinking Network Adequacy: Beyond Minimum Compliance Standards

Milliman examines how payers, including Medicaid plans, traditionally meet network adequacy requirements through geographic distance, provider-to-member ratios, and appointment wait time standards set by regulators like CMS and state Medicaid agencies. The piece argues that merely meeting these minimum regulatory thresholds doesn't necessarily optimize actual access to care or plan performance, suggesting more sophisticated approaches to network design are needed. This has direct implications for Medicaid MCOs navigating state network adequacy mandates and seeking to improve quality metrics.

milliman.com →
Milliman · May 21

Pharmacy Trends Roundup: PBM Pharmacy Ownership Bans, GLP-1 Costs, and Drug Pricing Executive Order

Milliman's monthly pharmacy briefing covers state and federal PBM reform efforts (including Arkansas's ban on PBM-owned retail pharmacies and a multi-state push for similar federal action), a presidential executive order targeting drug pricing, a CMS decision not to cover anti-obesity drugs under certain programs, and rising GLP-1 drug spend trends. While focused mainly on commercial and Medicare pharmacy dynamics, these PBM regulatory shifts and drug cost trends carry indirect implications for Medicaid pharmacy benefit design and managed care drug spend management.

milliman.com →
Milliman · May 1

Medicaid NEMT Delivery Models Compared Across Seven States: Cost and Administration Analysis

Milliman analyzed non-emergency medical transportation programs across seven state Medicaid clients, comparing delivery models and per-member-per-month costs as the NEMT market grows toward a projected $15.58 billion by 2028. The analysis examines how states exercise discretion in administering this federally required benefit, which serves 4-5% of Medicaid enrollees annually, and develops hypotheses for improving oversight and cost management. The findings are directly relevant to MCO finance teams and state Medicaid directors responsible for NEMT benefit design and vendor management.

milliman.com →
Milliman · Apr 11

D-SNP Benefit Value Declines in 2025 After Years of Growth, Milliman Finds

Milliman's updated analysis of 2025 Medicare Advantage enrollment data shows that average "value added" for dual-eligible special needs plans (D-SNPs) dropped significantly after years of steady enhancement, using the firm's proprietary MACVAT valuation methodology. Because D-SNPs serve beneficiaries dually eligible for Medicare and Medicaid, these benefit and premium trends matter directly to state Medicaid agencies and MCOs managing integrated care arrangements and contracting strategy for this high-cost, high-need population.

milliman.com →
Milliman · Mar 28

How Changes to Federal Medicaid Matching Rates Could Reshape State Budget Planning

Milliman actuaries examine the structure of federal matching rates (FMAP) across traditional Medicaid, ACA expansion populations, CHIP, and administrative costs, analyzing how potential shifts in federal matching formulas could impact state Medicaid budgets. The white paper models three alternative scenarios for matching rate changes and their financial implications for state Medicaid programs. This analysis is directly relevant to state Medicaid directors and MCO finance teams navigating budget uncertainty and potential federal policy changes that affect managed care capitation funding.

milliman.com →
Milliman · Mar 17

CMS Issues New Medicaid Rate-Setting Guidance for PACE Programs

CMS published updated guidance in December 2024 on how states should develop and document Medicaid capitation rates for PACE organizations, which provide comprehensive care to elderly enrollees. The white paper explains changes to rate-setting methodology, including how to calculate the "Amount That Would Have Otherwise Been Paid" (AWOP) benchmark and broader implications for Medicaid capitation rate development. This matters for state Medicaid directors and actuaries responsible for setting compliant rates for PACE plans, as well as MCOs and health plans considering or operating PACE programs.

milliman.com →
Milliman · Mar 3

Milliman Outlines Case Management Strategies for Medicaid MCOs Serving Sickle Cell Disease Populations

This white paper provides Medicaid managed care plans with a framework for optimizing care coordination for enrollees with sickle cell disease, addressing specialized service access, continuity of care, and patient education. It examines how technology can reduce avoidable costs and improve care coordination, and explores integrating federal disease action plans and health equity frameworks to reduce acute care utilization. The analysis is particularly timely given new gene therapy approvals that may reshape treatment approaches for this Medicaid population.

milliman.com →
Milliman · Jan 7

Designing Bundled Payment Models for Musculoskeletal Conditions: Key Features and Implementation Considerations

This white paper examines how health plans and provider organizations can structure bundled payment arrangements for musculoskeletal conditions like knee osteoarthritis, moving away from fee-for-service models. While the analysis applies broadly to value-based payment design across payers, the concepts are directly relevant to Medicaid managed care organizations exploring episode-based payment with orthopedic providers. The framework covers which organizations should enter bundled arrangements, model types, and why orthopedic episodes offer predictable cost and outcome patterns suitable for bundling.

milliman.com →

Get the daily briefing.